These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22985364)

  • 21. Current status of clinical trials for acute spinal cord injury.
    Fehlings MG; Baptiste DC
    Injury; 2005 Jul; 36 Suppl 2():B113-22. PubMed ID: 15993112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.
    Tator CH; Hashimoto R; Raich A; Norvell D; Fehlings MG; Harrop JS; Guest J; Aarabi B; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):157-229. PubMed ID: 22985382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Riluzole: a glimmer of hope in the treatment of motor neurone disease.
    Kiernan MC
    Med J Aust; 2005 Apr; 182(7):319-20. PubMed ID: 15804220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Riluzole for motor neurone disease. More trials are needed.
    Sandercock J; Burls A; Hyde C; Fry-Smith A; Barton P; Bryan S; Stewart A
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403060
    [No Abstract]   [Full Text] [Related]  

  • 25. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury.
    Hawryluk GW; Rowland J; Kwon BK; Fehlings MG
    Neurosurg Focus; 2008; 25(5):E14. PubMed ID: 18980474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury.
    Hosier H; Peterson D; Tsymbalyuk O; Keledjian K; Smith BR; Ivanova S; Gerzanich V; Popovich PG; Simard JM
    J Neurotrauma; 2015 Nov; 32(21):1633-44. PubMed ID: 26192071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repairing the damaged spinal cord.
    McDonald JW
    Sci Am; 1999 Sep; 281(3):64-73. PubMed ID: 10467750
    [No Abstract]   [Full Text] [Related]  

  • 28. A word of caution in extrapolating the riluzole spinal cord injury protective effects obtained in a rabbit model under ketamine anesthesia.
    Miyamoto TA; Miyamoto KJ
    J Thorac Cardiovasc Surg; 1999 Dec; 118(6):1156-7. PubMed ID: 10596003
    [No Abstract]   [Full Text] [Related]  

  • 29. Riluzole for motor neurone disease. Large, more economical trial is needed.
    Wheatley K; Gray R
    BMJ; 2001 May; 322(7297):1305. PubMed ID: 11403061
    [No Abstract]   [Full Text] [Related]  

  • 30. Mediating the Secondary Effects of Spinal Cord Injury Through Optimization of Key Physiologic Parameters.
    Haller J; Bice M; Lawrence B
    J Am Acad Orthop Surg; 2016 Mar; 24(3):160-71. PubMed ID: 26855116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping.
    Lang-Lazdunski L; Heurteaux C; Vaillant N; Widmann C; Lazdunski M
    J Thorac Cardiovasc Surg; 1999 May; 117(5):881-9. PubMed ID: 10220679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug evaluation: ProCord - a potential cell-based therapy for spinal cord injury.
    Kigerl K; Popovich P
    IDrugs; 2006 May; 9(5):354-60. PubMed ID: 16676272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylprednisolone and other confounders to spinal cord injury clinical trials.
    Sipski ML; Pearse DD
    Nat Clin Pract Neurol; 2006 Aug; 2(8):402-3. PubMed ID: 16932592
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on traumatic acute spinal cord injury. Part 1.
    Galeiras Vázquez R; Ferreiro Velasco ME; Mourelo Fariña M; Montoto Marqués A; Salvador de la Barrera S
    Med Intensiva; 2017 May; 41(4):237-247. PubMed ID: 28161028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages.
    Gensel JC; Donnelly DJ; Popovich PG
    Expert Opin Ther Targets; 2011 Apr; 15(4):505-18. PubMed ID: 21281256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Riluzole: what it does to spinal and brainstem neurons and how it does it.
    Cifra A; Mazzone GL; Nistri A
    Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection in spinal cord injury.
    Wyndaele JJ
    Spinal Cord; 2009 Oct; 47(10):715. PubMed ID: 19794416
    [No Abstract]   [Full Text] [Related]  

  • 39. Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy.
    Karadimas SK; Laliberte AM; Tetreault L; Chung YS; Arnold P; Foltz WD; Fehlings MG
    Sci Transl Med; 2015 Dec; 7(316):316ra194. PubMed ID: 26631633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From basics to clinical: a comprehensive review on spinal cord injury.
    Silva NA; Sousa N; Reis RL; Salgado AJ
    Prog Neurobiol; 2014 Mar; 114():25-57. PubMed ID: 24269804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.